OOIR: Observatory of International Research

Papers

(The H4-Index of Current Opinion in Microbiology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)

Article	Citations
Antibiotics: past, present and future	784
Global epidemiology of emerging Candida auris	156
Horizontal transfer of antibiotic resistance genes in the human gut microbiome	152
Candida albicans biofilm growth and dispersal: contributions to pathogenesis	121
Candidalysin: discovery and function in Candida albicans infections	115
The evolution and transmission of multi-drug resistant Escherichia coli and Klebsiella pneumoniae: the complexity of clones and plasmids	95
Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy	92
Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms	87
PANoptosis in microbial infection	78
Neonatal gut microbiome and immunity	75
The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine	69
Hepatitis E virus: host tropism and zoonotic infection	62
Recent and emerging technologies for the rapid diagnosis of infection and antimicrobial resistance	57
Unlocking the trove of metabolic treasures: activating silent biosynthetic gene clusters in bacteria and fungi	55
Linking bacterial growth, survival, and multicellularity – small signaling molecules as triggers and drivers	53
Engineering enzymatic assembly lines to produce new antibiotics	50
The antiviral activities of TRIM proteins	46
Mycoviruses and their role in fungal pathogenesis	45
The social life of microbes in chronic infection	44
When is a transcription factor a NAP?	44
The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae	44
Regulatory mechanisms controlling morphology and pathogenesis in Candida albicans	41
The potential of using E. coli as an indicator for the surveillance of antimicrobial resistance (AMR) in the environment	40
Natural products discovery and potential for new antibiotics	39
The assembly of β-barrel outer membrane proteins	38

PAS domains in bacterial signal transduction	37
Extracellular vesicles of human pathogenic fungi	37
The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria	37
Pseudomonas aeruginosa polymicrobial interactions during lung infection	36
A titanic drug resistance threat in Cryptococcus neoformans	35
Seizing the moment: now is the time for integrated global surveillance of antimicrobial resistance in wastewater environments	35
Immunoglobulin A and the microbiome	35
Toward computer-made artificial antibiotics	34
Translocation of effector proteins into host cells by Toxoplasma gondii	34